Table 2 Distribution of patients’ data on drug use

Drugs, n (%)

Metoprolol^†

157 (52.2)

74 (24.6)

331 (55.1)

0.150

Furosemide^†

84 (27.9)

60 (20.0)

144 (24.0)

0.023*

Warfarin^†

27 (9.0)

23 (7.7)

50 (8.3)

0.667

Colchicin^†

19 (6.3)

26 (8.7)

45 (7.5)

0.346

Digoxin^†

24 (8.0)

18 (6.0)

42 (7.0)

0.430

Isosorbide mononitrate^†

13 (4.3)

16 (5.3)

29 (4.8)

0.697

Trazodone^†

14 (4.7)

15 (5.0)

29 (4.8)

0.993

Desloratadine^†

10 (3.3)

10 (3.3)

20 (3.3)

1.000

Cetirizine^†

8 (2.7)

9 (3.0)

17 (2.8)

0.994

Fesoterodine^§

8 (2.7)

7 (2.3)

15 (2.5)

1.000

Tolterodine^§

10 (3.3)

5 (1.7)

15 (2.5)

0.299

Solifenacin^§

5 (1.7)

9 (3.0)

14 (2.3)

0.414

Trospium^§

9 (3.0)

4 (1.3)

13 (2.2)

0.262

Paroxetine^§

6 (2.0)

6 (2.0)

12 (2.0)

1.000

Risperidone^†

6 (2.0)

5 (1.7)

11 (1.8)

1.000

Venlafaxine^†

5 (1.7)

4 (1.3)

9 (1.5)

1.000

Levocetirizine^†

4 (1.3)

4 (1.3)

8 (1.3)

0.996

Nifedipine^†

3 (1.0)

3 (1.0)

6 (1.0)

1.000

Olanzapine^§

3 (1.0)

2 (0.7)

5 (0.8)

1.000

Carbamazepine^‡

3 (1.0)

2 (0.7)

5 (0.8)

1.000

Amitriptyline^§

3 (1.0)

2 (0.7)

5 (0.8)

1.000

Hydroxyzine^§

1 (0.3)

3 (1.0)

4 (0.7)

0.373

Alprazolam^†

1 (0.3)

3 (1.0)

4 (0.7)

0.373

Captopril^†

2 (0.7)

2 (0.7)

4 (0.7)

1.000

Dimenhydrinate^§

1 (0.3)

2 (0.7)

3 (0.5)

0.624

Trifluoperazine^§

2 (0.7)

1 (0.3)

3 (0.5)

1.000

Amantadine^‡

-

2 (0.7)

2 (0.3)

0.950

Doxylamine^§

1 (0.3)

1 (0.3)

2 (0.3)

1.000

Haloperidol^†

2 (0.7)

-

2 (0.3)

0.499

Darifenacin^§

-

1 (0.3)

1 (0.2)

0.499

Oxybutynin^§

1 (0.3)

-

1 (0.2)

1.000

Clozapine^§

1 (0.3)

-

1 (0.2)

1.000

Loratadine^†

1 (0.3)

-

1 (0.2)

1.000

Diazepam^†

1 (0.3)

-

1 (0.2)

1.000

Number of anticholinergic drugs, mean (SD)

Median (range)

1.45 (0.72)

1 (1–5)

1.41 (0.73)

1 (1–6)

1.43 (0.72)

1 (1–6)

0.991

Total number of daily drugs, mean (SD)

Median (range)

7.70 (3.18)

7 (1–21)

7.61 (3.40)

7 (1–17)

7.65 (3.39)

7 (1–21)

0.966

Polypharmacy (≥ 5), n (%)

254 (84.4)

241 (80.3)

495 (82.4)

0.193

Number of anticholinergic drugs to total number of daily drugs ratio, mean (SD)

Median (range)

0.22 (0.13)

0.18 (0.06-1)

0.22 (0.45)

0.17 (0.06-1)

0.22 (0.14)

0.18 (0.06-1)

0.983

Pre-intervention ACBS, mean (SD)

Median (range)

1.78 (1.17)

1 (1–9)

1.72 (1.17)

1 (1–10)

1.75 (1.17)

1 (1–10)

0.918

Pre-intervention ACBS (high risk), n (%)

66 (21.9)

62 (20.7)

128 (21.3)

0.706

Post-intervention ACBS, mean (SD)

Median (range)

-

1.64 (1.08)

1 (0–10)

1.71 (1.13)

1 (0–10)

0.813

Post-intervention ACBS (high risk), n (%)

-

60 (20.0)

126 (21.0)

0.562